Details werden geladen...
Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026 | The Manila Times
COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.
Ähnliche Seiten
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026 | The Manila Times
https://www.manilatimes.net/2026/05/29/tmt-newswire/globenewswire/rhythm-pharmaceuticals-announces-seven-abstracts-accepted-for-presentation-at-endo-2026/2354510Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349713Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting | The Manila Times
https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/axsome-therapeutics-presents-new-symbravo-data-at-the-americal-headache-society-ahs-68th-annual-scientific-meeting/2358626HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting/2349755BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/beyondspring-announces-poster-presentation-at-2026-asco-annual-meeting/2346086